Social Media Influencers Fueling Parallel Trade for Unapproved Weight-Loss Drug

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting substances of uncertain source.

Some experts said the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, legal action or prison.

Service Response and Material Removal

According to TikTok, the service has taken down problematic material and prohibited related keywords and query recommendations. The organization said it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at home.

After moments of entering one group, a vendor shared WhatsApp details, where most purchases take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, posts display dark colored packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When questioned how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.